XTAE:EVGN (Israel)  
Evogene Ltd logo

Evogene Ltd

₪ 2.17 (-0.28%) Dec 6
P/E:
At Loss
P/B:
0.86
Market Cap:
₪ 89.48M ($ 26.15M)
Enterprise V:
₪ 931.00K ($ 272.00K)
Volume:
38.96K
Avg Vol (2M):
92.13K
Also Trade In:
Volume:
38.96K
Market Cap ₪:
89.48M
Market Cap $:
26.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
92.13K
Enterprise Value ₪:
931.00K
Enterprise Value $:
272.00K
PB Ratio:
0.86
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.
Name Current Vs Industry Vs History
Cash-To-Debt 3.18
Equity-to-Asset 0.52
Debt-to-Equity 0.39
Debt-to-EBITDA -0.43
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.64
Distress
Grey
Safe
Beneish M-Score -3.04
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 32.45
9-Day RSI 32.69
14-Day RSI 33.77
6-1 Month Momentum % -13.94
12-1 Month Momentum % -53.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.3
Quick Ratio 7.27
Cash Ratio 6.8
Days Inventory 66.41
Days Sales Outstanding 63.92
Days Payable 625.71

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.9

Financials (Next Earnings Date:2023-03-10 Est.)

XTAE:EVGN's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₪) 4.514
EPS (TTM) (₪) -2.554
Beta 0
Volatility % 67.48
14-Day RSI 33.77
14-Day ATR (₪) 0.101408
20-Day SMA (₪) 2.3361
12-1 Month Momentum % -53.8
52-Week Range (₪) 2.1 - 6.45
Shares Outstanding (Mil) 41.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Evogene Ltd Filings

Document Form Filing Date
No Filing Data

Evogene Ltd Analysis

Share your research